Termination by Amgen. a. If the ***** has not been identified, as that research milestone is defined in Section 8.4.a., on or before ***** months from the Effective Date, Amgen may, at its option, provide written notice of termination to GENE at any time thereafter until such time as the ***** is identified or Amgen elects to advance the Research Program to the ***** of the Research Plan pursuant to Section 8.4.a., and the Agreement shall automatically terminate ***** days after such prior written notice of termination is provided to GENE. b. At any time after the ***** has been identified, Amgen shall have the right, in its sole discretion, to terminate this Agreement by providing ***** days prior written notice of termination to GENE. c. The effects of any such termination under this Section 15.2 will occur in accordance with Section 15.6.
Appears in 2 contracts
Sources: Research Collaboration and License Agreement (Genome Therapeutics Corp), Research Collaboration and License Agreement (Genome Therapeutics Corp)